Eviplera

Gilead Sciences (NASDAQ: GILD) is down less than one percent in after hours trading after the company announced its fourth quarter results. The company reported a Q4 EPS of $0.55 versus the Street estimate of $0.50. Earnings per share were up 10 percent from the year-ago period. Revenue arrived...